Cytosorbents Corporation Share Price
Equities
CTSO
US23283X2062
Advanced Medical Equipment & Technology
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.9001 USD | +2.28% | +0.01% | -18.91% |
05-09 | Earnings Flash (CTSO) CYTOSORBENTS Posts Q1 Revenue $9.8M, vs. Street Est of $9.79M | MT |
05-09 | Transcript : Cytosorbents Corporation, Q1 2024 Earnings Call, May 09, 2024 |
Sales 2024 * | 39.52M 3.1B | Sales 2025 * | 46.83M 3.68B | Capitalization | 48.88M 3.84B |
---|---|---|---|---|---|
Net income 2024 * | -20M -1.57B | Net income 2025 * | -9M -706M | EV / Sales 2024 * | 1.24 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 1.04 x |
P/E ratio 2024 * |
-2.45
x | P/E ratio 2025 * |
-5
x | Employees | 186 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 96.8% |
Latest transcript on Cytosorbents Corporation
1 day | +2.28% | ||
1 week | +0.01% | ||
1 month | +9.85% | ||
3 months | -5.12% | ||
6 months | -23.07% | ||
Current year | -18.91% |
Managers | Title | Age | Since |
---|---|---|---|
Phillip Chan
CEO | Chief Executive Officer | 53 | 23/07/08 |
Vincent Capponi
PSD | President | 66 | 24/04/02 |
Kathleen Bloch
DFI | Director of Finance/CFO | 69 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Michael Bator
CHM | Chairman | 60 | 13/07/15 |
Phillip Chan
CEO | Chief Executive Officer | 53 | 23/07/08 |
Edward Jones
BRD | Director/Board Member | 75 | 31/03/07 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.20% | 12 M€ | -.--% | - |
Date | Price | Change | Volume |
---|---|---|---|
31/05/24 | 0.9001 | +2.28% | 53,514 |
30/05/24 | 0.88 | -2.22% | 29,934 |
29/05/24 | 0.9 | +4.41% | 29,464 |
28/05/24 | 0.862 | -4.22% | 51,473 |
Delayed Quote Nasdaq, May 31, 2024 at 09:00 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-18.91% | 48.88M | |
+7.01% | 217B | |
+11.01% | 190B | |
+19.20% | 143B | |
+30.79% | 111B | |
+1.48% | 64.59B | |
+13.95% | 52.36B | |
-0.16% | 48.45B | |
-6.20% | 38.03B | |
+0.91% | 35.6B |
- Stock Market
- Equities
- CTSO Stock